SMTL ID : 9dtx.1

Crystal structure of PRT3789 in complex with the bromodomain of human BRG1 (SMARCA4) and pVHL:ElonginC:ElonginB

Coordinates
PDB Format
Method
X-RAY DIFFRACTION 2.11 Å
Oligo State
hetero-1-1-1-1-mer
Ligands
1 x 01: (4R)-4-hydroxy-1-[(2R)-2-(3-{[(2S)-1-{(3R)-3-[(2M,6aS,11S)-2-(2-hydroxyphenyl)-5,6,6a,7,9,10-hexahydro-8H-pyrazino[1',2':4,5]pyrazino[2,3-c]pyridazin-8-yl]pyrrolidin-1-yl}propan-2-yl]oxy}-1,2-oxazol-5-yl)-3-methylbutanoyl]-N-{(1S)-1-[4-(4-methyl-1,3-thiazol-5-yl)phenyl]ethyl}-L-prolinamide
1 x GOL: GLYCEROL(Non-functional Binders)
1 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
1 x CL: CHLORIDE ION(Non-functional Binders)
Links
RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP
Citation
Hulse, M. et al., PRT3789 is a First-in-Human SMARCA2-Selective Degrader that Induces Synthetic Lethality in SMARCA4-Mutated Cancers. Cancer Res. (2025)
Release Date
2025-10-01
Peptides
Elongin-B: A
Elongin-C: B
von Hippel-Lindau disease tumor suppressor: C
Transcription activator BRG1: D
SMTL:PDB
SMTL Chain Id:
PDB Chain Id:
A
A
B
B
C
C
D
D

Elongin-B

Elongin-C

von Hippel-Lindau disease tumor suppressor

Transcription activator BRG1

Related Entries With Identical Sequence

1lm8.1 | 1lqb.1 | 1lqb.2 | 2fnj.1 | 2jz3.1 | 3zkj.1 | 3zkj.2 | 4awj.1 | 4awj.2 | 4awj.3 | 4awj.4 | 4b9k.1 | 4b9k.2 | 4b9k.3 | 4b9k.4 | 4bks.1 | 4bks.2 | 4bks.3 | 4bks.4 | 4bkt.1 | 4bkt.2 | 4bkt.3 | 4bkt.4 | 4n9f.1 | 4n9f.2 | 4n9f.3 | 4n9f.4 | 4n9f.5 | 4n9f.6 | 4n9f.7  more...